VolitionRx Limited Extends Clinical Trial Program in Lung Cancer
VolitionRx Limited Signs Memorandum of Understanding with Fosun Long March in China
VolitionRx Limited to Present at Conferences in March & April 2019
VolitionRx Limited to Present at Conferences in the U.S. Next Week
VolitionRx Limited Announces Full Fiscal Year 2018 Financial Results and Business Update
VolitionRx Limited Schedules Full Year 2018 Earnings Conference Call and Business Update
VolitionRx Limited Announces Third Quarter 2018 Financial Results and Business Update
VolitionRx Limited Schedules Third Quarter 2018 Earnings Conference Call and Business Update
VolitionRx Limited to Expand its Nu.Q(TM) Trials to Veterinary Diagnostics
VolitionRx Limited Releases Video Featuring Interviews with its Scientific Advisory Board
